Skip to main content

5 articles related to "Cimavax Egf"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 03 Aug 2022

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

in Thoracic Oncology

Rachel Evans
Kelvin Lee
Paul K. Wallace
Mary Reid
Jason Muhitch
Askia Dozier
Circe Mesa
Patricia L. Luaces
Orestes Santos-Morales
Adrienne Groman

Frontiers in Oncology

doi 10.3389/fonc.2022.958043

6,622 views
11 citations

Review

Published on 15 Jun 2021

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Tania Crombet Ramos
Orestes Santos Morales
Grace K. Dy
Kalet León Monzón
Agustín Lage Dávila

Frontiers in Oncology

doi 10.3389/fonc.2021.639745

9,062 views
16 citations

Review

Published on 13 Mar 2017

CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients

in Cancer Immunity and Immunotherapy

Danay Saavedra
Tania Crombet

Frontiers in Immunology

doi 10.3389/fimmu.2017.00269

48,888 views
82 citations

Clinical Trial

Published on 18 Jan 2024

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

in Thoracic Oncology

Ramón A. Ortiz Carrodeguas
Geidy Lorenzo Monteagudo
Pedro P. Guerra Chaviano
Irene Álvarez Montané
Eva E. Salomón Saldívar
Leonardo Lobaina Lambert
Kirenia Camacho Sosa
Raúl Bermúdez Pino
Poncio Blanco Mustelier
Elba Valdés Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1287902

8,043 views
11 citations

Original Research

Published on 27 Jan 2022

Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy

in Cancer Immunity and Immunotherapy

Gisela María Suárez
Mauricio Catalá
Yadira Peña
Susana Portela
Ana Laura Añé-Kourí
Amnely González
Patricia Lorenzo-Luaces
Manuel Díaz
María de los A. Molina
Karla Pereira

Frontiers in Oncology

doi 10.3389/fonc.2022.823287

3,859 views
9 citations